Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes

We aimed to investigate outcomes of different post-remission treatment (PRT) choices based on dynamic measurable residual disease (MRD) by multiparameter flow cytometry in favorable-risk AML (FR-AML). Four hundred and three younger patients with FR-AML in first complete remission (CR1) were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Sijian, Lin, Tong, Nie, Danian, Zhang, Yu, Sun, Zhiqiang, Zhang, Qing, Wang, Caixia, Xiong, Mujun, Fan, Zhiping, Huang, Fen, Xu, Na, Liu, Hui, Yu, Guopan, Zhang, Hongyu, Shi, Pengcheng, Xu, Jun, Xuan, Li, Guo, Ziwen, Wu, Meiqing, Han, Lijie, Xiong, Yiying, Sun, Jing, Wang, Yu, Liu, Qifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648754/
https://www.ncbi.nlm.nih.gov/pubmed/34873148
http://dx.doi.org/10.1038/s41408-021-00591-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648754/
https://www.ncbi.nlm.nih.gov/pubmed/34873148
http://dx.doi.org/10.1038/s41408-021-00591-4

Ejemplares similares